NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Genvor Inc. Partnership with B2i Digital for Investor Awareness Expansion
TL;DR
Genvor's AI-accelerated peptide platform offers agricultural companies a competitive edge by reducing crop losses through sustainable biological solutions that outperform traditional methods.
Genvor's BioCypher Algorithm leverages 50,000 designed peptides and 30 years of research to systematically develop targeted solutions that reduce aflatoxin contamination by 76-98% in crops.
Genvor's sustainable agricultural solutions help create a better tomorrow by reducing global crop losses and providing safer, biological alternatives to chemical pesticides for food production.
Genvor's AI platform designs peptides that can reduce fungal toxins in corn by up to 98%, using computational biology to revolutionize crop protection.
Found this article helpful?
Share it with your network and spread the knowledge!
The partnership aims to expand Genvor's investor awareness and engagement by leveraging B2i Digital's multi-channel digital marketing engine and targeted outreach campaigns to reach interested investors.
Genvor is an agricultural biotechnology company that develops sustainable crop-protection solutions through AI-accelerated peptide design, including antimicrobial, insecticidal, and nutrient-enhancing peptides using their proprietary BioCypher Algorithm.
The BioCypher Algorithm leverages more than 50,000 designed peptides and over 30 years of foundational research to produce targeted solutions for major agricultural challenges, demonstrating broad-spectrum efficacy against plant pathogens.
Genvor's platform has demonstrated 76%–98% reductions in total aflatoxin contamination in transgenic corn seeds across pathogens such as Aspergillus flavus and Fusarium species.
Genvor follows a licensing-first business model and is currently experiencing accelerated momentum with recently issued patents, active partnership discussions, and a growing pipeline of agricultural solutions.
Genvor maintains a growing intellectual property portfolio including two issued U.S. patents and one pending application covering 24 proprietary peptides, with their most recent patent issued in November 2025 for transgenic corn expressing antifungal peptide AGM182.
Genvor's development pipeline spans multiple crops including corn, citrus, rice, soybeans, cotton, flax, and potato, with applications across both foliar spray solutions and seed traits.
B2i Digital is a firm that partners with public companies through its Featured Company program, delivering executive-level investor engagement and institutional-quality exposure through its proprietary network of more than 1.4 million market participants and digital marketing technology.
This partnership comes at a key moment as Genvor continues its accelerated momentum with recently issued patents, active partnership discussions, and a growing pipeline, making it an ideal time to expand investor engagement.
Genvor's technology targets the estimated $220 billion in annual global crop losses caused by plant pathogens, representing a significant market opportunity for sustainable crop protection solutions.
Curated from NewMediaWire
